Literature DB >> 17636446

Luteal phase oestradiol administration in ovarian stimulation cycles with GnRH antagonist is comparable to the GnRH agonist (long) protocol.

J S Cunha Filho1, L F Terres, F Holanda, F Freitas, C Glitz, V K Genro, E Arbo.   

Abstract

PURPOSE: The purpose of the study was to compare the effectiveness of GnRH antagonist with luteal phase estradiol administration to GnRH agonist cycles, long protocol.
METHODS: 55 IVF-ICSI patients received oestradiol in the luteal phase of the cycle, before a cycle with GnRH antagonist. Fifty-five patients submitted to IVF-ICSI with the use of agonist were allocated, age matched, as a control group (historical control). The primary outcome was the number of retrieved oocytes.
RESULTS: Patients were similar in terms of clinical characteristics. No differences were found in the number of oocytes retrieved (study group, 8.1 +/- 4.7; control group, 7.4 +/- 4.5) or in oocyte quality.
CONCLUSIONS: We clearly demonstrated that the effectiveness of GnRH antagonist when combined with luteal phase estradiol is comparable to GnRH agonist cycles.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17636446      PMCID: PMC3454939          DOI: 10.1007/s10815-007-9125-x

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  15 in total

1.  Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation.

Authors: 
Journal:  Hum Reprod       Date:  2001-04       Impact factor: 6.918

2.  Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists.

Authors:  Renato Fanchin; Laurent Salomon; Altina Castelo-Branco; François Olivennes; Nelly Frydman; René Frydman
Journal:  Hum Reprod       Date:  2003-12       Impact factor: 6.918

3.  Tailoring the GnRH antagonist cetrorelix acetate to individual patients' needs in ovarian stimulation for IVF: results of a prospective, randomized study.

Authors:  M Ludwig; A Katalinic; C Banz; A K Schröder; M Löning; J M Weiss; K Diedrich
Journal:  Hum Reprod       Date:  2002-11       Impact factor: 6.918

4.  Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).

Authors:  F Olivennes; J Belaisch-Allart; J C Emperaire; H Dechaud; S Alvarez; L Moreau; B Nicollet; J R Zorn; P Bouchard; R Frydman
Journal:  Fertil Steril       Date:  2000-02       Impact factor: 7.329

5.  Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group.

Authors:  C Albano; R E Felberbaum; J Smitz; H Riethmüller-Winzen; J Engel; K Diedrich; P Devroey
Journal:  Hum Reprod       Date:  2000-03       Impact factor: 6.918

6.  Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group.

Authors:  G Borm; B Mannaerts
Journal:  Hum Reprod       Date:  2000-07       Impact factor: 6.918

7.  Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation.

Authors:  M Fluker; J Grifo; A Leader; M Levy; D Meldrum; S J Muasher; J Rinehart; Z Rosenwaks; R T Scott; W Schoolcraft; D B Shapiro
Journal:  Fertil Steril       Date:  2001-01       Impact factor: 7.329

8.  GnRH antagonist in assisted reproduction: a Cochrane review.

Authors:  Hesham Al-Inany; Mohamed Aboulghar
Journal:  Hum Reprod       Date:  2002-04       Impact factor: 6.918

Review 9.  The use of GnRH antagonists in ovarian stimulation.

Authors:  F Olivennes; J S Cunha-Filho; R Fanchin; P Bouchard; R Frydman
Journal:  Hum Reprod Update       Date:  2002 May-Jun       Impact factor: 15.610

10.  Coordination of early antral follicles by luteal estradiol administration provides a basis for alternative controlled ovarian hyperstimulation regimens.

Authors:  Renato Fanchin; João Sabino Cunha-Filho; Luca Maria Schonäuer; Isaac Jacques Kadoch; Paul Cohen-Bacri; René Frydman
Journal:  Fertil Steril       Date:  2003-02       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.